Ming‐whei Yu - Epidemiology

Author Information

Ming-Whei Yu is affiliated with the Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan. Ming-Whei Yu has made significant contributions to the field of epidemiology, particularly focusing on the interplay between hepatitis B virus (HBV) infection, metabolic factors, and the development of hepatocellular carcinoma (HCC).

Research Contributions

Ming-Whei Yu's research predominantly centers on understanding the risk factors and mechanisms underlying hepatocellular carcinoma in the context of chronic hepatitis B infection. The author has explored various aspects such as the impact of genetic polymorphisms (e.g., PNPLA3 p.I148M), hepatic steatosis, and metabolic risk factors on the progression and outcomes of HCC. Studies have also delved into the role of viral load, alanine aminotransferase levels, and epigenetic modifications in mediating HCC risk among HBV carriers. The work extends to identifying blood DNA methylation patterns and genetic haplotypes associated with early-onset HCC development, indicating a comprehensive approach to understanding and potentially mitigating the disease.

Aliases

Ming-Whei Yu is also known by the aliases M-w Yu and Ming-whei Yu.

Publication and Citation Metrics

Metric	Value
Citation Count	5066
h-index	35
Paper Count	67

Publications:

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B

DOI: 10.2147/JHC.S355540

Year: 2022

Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors.

DOI: 10.1016/j.jfma.2021.10.014

Year: 2021

Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase

DOI: 10.1002/hep.30339

Year: 2019

THU-241-Influence of HBV genotype on the risk of hepatocellular carcinoma: mediating roles of different phase of viral infection and epigenetic modifications

DOI: 10.1016/S0618-8278(19)30514-6

Year: 2019

Identifying epigenetic markers for characterization of host response to hepatitis B virus infection during the development of hepatocellular carcinoma

DOI: 10.1016/S0168-8278(18)31203-0

Year: 2018

Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.

DOI: 10.1053/j.gastro.2017.07.001

Year: 2017

Genome‐wide identification of blood DNA methylation patterns associated with early‐onset hepatocellular carcinoma development in hepatitis B carriers

DOI: 10.1002/mc.22505

Year: 2017

Genome‐wide association analysis identifies a GLUL haplotype for familial hepatitis B virus‐related hepatocellular carcinoma

DOI: 10.1002/cncr.30851

Year: 2017

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma

DOI: 10.1002/hep.28654

Year: 2016

Metabolic Syndrome and Hepatocellular Carcinoma Risk in Hepatitis B: A Prospective Study

DOI: 10.1016/S0168-8278(16)00515-8

Year: 2016

What are the Demographic Patterns in Tobacco Use?

Why is Expert Review Important?

How is Cluster Sampling Conducted?

Why are Predictive Biomarkers Important?

How Prevalent is Inappropriate Prescribing?

1. What is the Study Objective?

What are the Limitations of FFQs?

How Can Technology Enhance Communication?

How Does Socioeconomic Status Impact Health?

What are Key Databases for Epidemiological Research?

Partnered Content Networks

Relevant Topics